Find verified Miglustat API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Miglustat for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Miglustat API.
Alternate Names: Butyldeoxynojirimycin, N-Butylmoranoline, Zavesca, Yargesa
CAS No: 72599-27-0
PubChem CID: 51634
Mol Formula: C10H21NO4
Mol Weight: 219.28 g/mol
IUPAC Name: (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
API Description: Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase.
